| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart-Assist Devices | 63 | 2022 | 760 | 9.730 |
Why?
|
| Heart Failure | 51 | 2022 | 1188 | 6.560 |
Why?
|
| Heart Transplantation | 10 | 2023 | 717 | 3.380 |
Why?
|
| Cardiac Surgical Procedures | 11 | 2021 | 479 | 2.730 |
Why?
|
| Heart Valve Prosthesis Implantation | 10 | 2023 | 178 | 2.420 |
Why?
|
| Ventricular Function, Left | 21 | 2021 | 607 | 2.310 |
Why?
|
| Diverticulum | 4 | 2021 | 45 | 2.140 |
Why?
|
| Hemodynamics | 17 | 2020 | 731 | 2.060 |
Why?
|
| Tissue Engineering | 7 | 2016 | 189 | 1.980 |
Why?
|
| Aorta, Thoracic | 8 | 2022 | 168 | 1.870 |
Why?
|
| Aortic Valve Insufficiency | 9 | 2021 | 132 | 1.770 |
Why?
|
| Prosthesis Implantation | 9 | 2020 | 126 | 1.680 |
Why?
|
| Heart Ventricles | 16 | 2020 | 779 | 1.600 |
Why?
|
| Retrospective Studies | 48 | 2023 | 9100 | 1.580 |
Why?
|
| Subclavian Artery | 4 | 2021 | 43 | 1.540 |
Why?
|
| Tricuspid Valve Insufficiency | 5 | 2023 | 115 | 1.390 |
Why?
|
| Aortic Aneurysm, Thoracic | 4 | 2021 | 89 | 1.350 |
Why?
|
| Cannula | 7 | 2020 | 50 | 1.260 |
Why?
|
| Extracellular Matrix | 4 | 2016 | 245 | 1.260 |
Why?
|
| Heart Valve Diseases | 4 | 2018 | 115 | 1.250 |
Why?
|
| Coronary Sinus | 2 | 2020 | 8 | 1.240 |
Why?
|
| Aortic Valve | 12 | 2021 | 244 | 1.240 |
Why?
|
| Cardioplegic Solutions | 2 | 2020 | 17 | 1.240 |
Why?
|
| Pericardium | 7 | 2018 | 70 | 1.240 |
Why?
|
| Intra-Aortic Balloon Pumping | 6 | 2022 | 79 | 1.220 |
Why?
|
| Middle Aged | 80 | 2022 | 26129 | 1.210 |
Why?
|
| Humans | 117 | 2023 | 89760 | 1.160 |
Why?
|
| Myocardium | 5 | 2021 | 572 | 1.130 |
Why?
|
| Treatment Outcome | 38 | 2023 | 8283 | 1.110 |
Why?
|
| Hospital Mortality | 6 | 2022 | 391 | 1.070 |
Why?
|
| Postoperative Complications | 15 | 2022 | 2290 | 1.060 |
Why?
|
| Extracorporeal Membrane Oxygenation | 3 | 2022 | 183 | 1.060 |
Why?
|
| Deglutition Disorders | 2 | 2020 | 119 | 1.060 |
Why?
|
| Mitral Valve | 7 | 2021 | 262 | 1.040 |
Why?
|
| Sternotomy | 3 | 2022 | 24 | 1.040 |
Why?
|
| Heart Atria | 5 | 2020 | 282 | 1.010 |
Why?
|
| Device Removal | 4 | 2020 | 168 | 0.990 |
Why?
|
| Male | 81 | 2022 | 42632 | 0.970 |
Why?
|
| Aged | 54 | 2022 | 19280 | 0.950 |
Why?
|
| Female | 82 | 2022 | 46439 | 0.950 |
Why?
|
| Gastrointestinal Hemorrhage | 5 | 2020 | 237 | 0.930 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2023 | 14 | 0.900 |
Why?
|
| Ventricular Function, Right | 5 | 2020 | 146 | 0.890 |
Why?
|
| Aortic Rupture | 2 | 2022 | 57 | 0.880 |
Why?
|
| Atrioventricular Block | 1 | 2023 | 25 | 0.880 |
Why?
|
| Catheter Ablation | 5 | 2008 | 253 | 0.870 |
Why?
|
| Regeneration | 3 | 2016 | 151 | 0.850 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2021 | 227 | 0.850 |
Why?
|
| Ventricular Dysfunction, Right | 3 | 2020 | 136 | 0.840 |
Why?
|
| Robotics | 4 | 2011 | 269 | 0.820 |
Why?
|
| Recovery of Function | 5 | 2021 | 293 | 0.790 |
Why?
|
| Mitral Valve Insufficiency | 4 | 2016 | 192 | 0.760 |
Why?
|
| Ventricular Remodeling | 2 | 2015 | 107 | 0.750 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2022 | 95 | 0.740 |
Why?
|
| Thrombosis | 5 | 2020 | 302 | 0.740 |
Why?
|
| Swine | 12 | 2017 | 587 | 0.730 |
Why?
|
| Tricuspid Valve | 5 | 2023 | 99 | 0.720 |
Why?
|
| Echocardiography, Doppler | 8 | 2020 | 186 | 0.700 |
Why?
|
| Heart Arrest, Induced | 2 | 2020 | 29 | 0.690 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2020 | 74 | 0.680 |
Why?
|
| Pulmonary Wedge Pressure | 6 | 2020 | 113 | 0.680 |
Why?
|
| Heart Rate | 2 | 2022 | 498 | 0.680 |
Why?
|
| Vena Cava, Superior | 2 | 2020 | 60 | 0.670 |
Why?
|
| Heart | 5 | 2019 | 574 | 0.660 |
Why?
|
| Endocarditis, Bacterial | 2 | 2011 | 39 | 0.650 |
Why?
|
| Defibrillators, Implantable | 3 | 2021 | 145 | 0.640 |
Why?
|
| Robotic Surgical Procedures | 2 | 2021 | 313 | 0.630 |
Why?
|
| Pacemaker, Artificial | 3 | 2020 | 96 | 0.620 |
Why?
|
| Carbon Dioxide | 1 | 2019 | 201 | 0.610 |
Why?
|
| Cardiac Catheterization | 6 | 2020 | 303 | 0.610 |
Why?
|
| Time Factors | 17 | 2020 | 5346 | 0.610 |
Why?
|
| Minimally Invasive Surgical Procedures | 5 | 2021 | 256 | 0.610 |
Why?
|
| Thromboembolism | 4 | 2019 | 120 | 0.600 |
Why?
|
| Echocardiography, Three-Dimensional | 6 | 2018 | 518 | 0.570 |
Why?
|
| Coronary Artery Bypass | 3 | 2020 | 236 | 0.560 |
Why?
|
| Hepatocyte Growth Factor | 2 | 2008 | 85 | 0.560 |
Why?
|
| Follow-Up Studies | 17 | 2020 | 3672 | 0.560 |
Why?
|
| Survival Rate | 8 | 2022 | 1910 | 0.550 |
Why?
|
| Clinical Competence | 1 | 2022 | 785 | 0.550 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2015 | 331 | 0.530 |
Why?
|
| Cohort Studies | 9 | 2022 | 2882 | 0.510 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2015 | 57 | 0.510 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2015 | 7 | 0.500 |
Why?
|
| Vascular Malformations | 1 | 2015 | 19 | 0.490 |
Why?
|
| Prosthesis Design | 11 | 2020 | 298 | 0.490 |
Why?
|
| Drug Carriers | 1 | 2015 | 82 | 0.490 |
Why?
|
| Counterpulsation | 3 | 2020 | 21 | 0.480 |
Why?
|
| Image Interpretation, Computer-Assisted | 5 | 2017 | 691 | 0.480 |
Why?
|
| Aneurysm | 1 | 2015 | 60 | 0.480 |
Why?
|
| Adult | 29 | 2022 | 26742 | 0.470 |
Why?
|
| Electrocardiography | 6 | 2021 | 497 | 0.460 |
Why?
|
| Cysts | 1 | 2015 | 106 | 0.460 |
Why?
|
| Echocardiography | 12 | 2020 | 938 | 0.450 |
Why?
|
| Shock, Cardiogenic | 4 | 2017 | 107 | 0.450 |
Why?
|
| Intestine, Small | 1 | 2015 | 299 | 0.440 |
Why?
|
| Endoscopy | 3 | 2020 | 351 | 0.430 |
Why?
|
| Risk Assessment | 9 | 2021 | 2309 | 0.430 |
Why?
|
| Stroke Volume | 5 | 2022 | 465 | 0.420 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2013 | 55 | 0.420 |
Why?
|
| Cardiac Output | 5 | 2020 | 155 | 0.420 |
Why?
|
| Prospective Studies | 20 | 2020 | 4328 | 0.410 |
Why?
|
| Atrial Fibrillation | 4 | 2018 | 357 | 0.410 |
Why?
|
| Reoperation | 7 | 2020 | 603 | 0.400 |
Why?
|
| Heart Injuries | 1 | 2011 | 19 | 0.390 |
Why?
|
| Chordae Tendineae | 3 | 2015 | 23 | 0.380 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 98 | 0.360 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2011 | 113 | 0.350 |
Why?
|
| Proportional Hazards Models | 6 | 2020 | 856 | 0.340 |
Why?
|
| Mathematical Concepts | 2 | 2020 | 19 | 0.340 |
Why?
|
| Risk Factors | 15 | 2022 | 5522 | 0.340 |
Why?
|
| Postoperative Hemorrhage | 1 | 2010 | 46 | 0.340 |
Why?
|
| Thoracotomy | 3 | 2021 | 64 | 0.340 |
Why?
|
| Bioprosthesis | 3 | 2017 | 39 | 0.340 |
Why?
|
| Anticoagulants | 5 | 2019 | 428 | 0.330 |
Why?
|
| Hematoma | 1 | 2010 | 108 | 0.330 |
Why?
|
| Fatty Acids, Omega-3 | 2 | 2019 | 51 | 0.320 |
Why?
|
| Aorta | 5 | 2022 | 289 | 0.320 |
Why?
|
| Incidence | 7 | 2021 | 1599 | 0.310 |
Why?
|
| Injections | 1 | 2008 | 116 | 0.310 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2008 | 10 | 0.300 |
Why?
|
| Reproducibility of Results | 10 | 2018 | 2766 | 0.300 |
Why?
|
| Body Surface Potential Mapping | 1 | 2007 | 25 | 0.300 |
Why?
|
| Equipment Design | 5 | 2016 | 420 | 0.290 |
Why?
|
| Cardiopulmonary Bypass | 2 | 2014 | 157 | 0.290 |
Why?
|
| Magnetic Resonance Imaging, Cine | 3 | 2018 | 164 | 0.290 |
Why?
|
| Atrial Function, Left | 1 | 2007 | 51 | 0.290 |
Why?
|
| Guanidines | 1 | 2007 | 31 | 0.290 |
Why?
|
| Gamma Rays | 1 | 2007 | 73 | 0.290 |
Why?
|
| Heart Valve Prosthesis | 3 | 2021 | 98 | 0.280 |
Why?
|
| Assisted Circulation | 2 | 2018 | 16 | 0.280 |
Why?
|
| Protease Inhibitors | 1 | 2007 | 73 | 0.280 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2008 | 98 | 0.270 |
Why?
|
| Tachycardia, Ventricular | 1 | 2007 | 124 | 0.270 |
Why?
|
| Echocardiography, Transesophageal | 4 | 2015 | 347 | 0.270 |
Why?
|
| Recurrence | 5 | 2018 | 1144 | 0.270 |
Why?
|
| Hemorrhage | 2 | 2018 | 284 | 0.270 |
Why?
|
| Animals | 17 | 2017 | 27456 | 0.260 |
Why?
|
| Intracranial Hemorrhages | 1 | 2007 | 130 | 0.260 |
Why?
|
| Network Meta-Analysis | 2 | 2022 | 6 | 0.250 |
Why?
|
| Liver Transplantation | 1 | 2012 | 1171 | 0.250 |
Why?
|
| Coronary Artery Bypass, Off-Pump | 2 | 2020 | 40 | 0.250 |
Why?
|
| Fibronectins | 1 | 2005 | 101 | 0.250 |
Why?
|
| Xiphoid Bone | 3 | 2009 | 3 | 0.240 |
Why?
|
| Models, Animal | 2 | 2016 | 276 | 0.240 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 359 | 0.240 |
Why?
|
| Stroke | 4 | 2022 | 988 | 0.240 |
Why?
|
| Heart Defects, Congenital | 1 | 2007 | 365 | 0.240 |
Why?
|
| Registries | 4 | 2022 | 792 | 0.230 |
Why?
|
| Atrial Appendage | 2 | 2018 | 33 | 0.230 |
Why?
|
| Chicago | 2 | 2019 | 1436 | 0.230 |
Why?
|
| Pulmonary Artery | 2 | 2020 | 319 | 0.220 |
Why?
|
| Sensitivity and Specificity | 7 | 2017 | 2019 | 0.220 |
Why?
|
| Endothelium, Vascular | 1 | 2005 | 433 | 0.220 |
Why?
|
| Endocarditis | 2 | 2021 | 22 | 0.220 |
Why?
|
| Central Venous Pressure | 2 | 2020 | 26 | 0.210 |
Why?
|
| Equipment Failure | 4 | 2018 | 120 | 0.210 |
Why?
|
| Hypothermia | 1 | 2022 | 26 | 0.210 |
Why?
|
| Arterial Pressure | 2 | 2020 | 38 | 0.210 |
Why?
|
| Myocardial Contraction | 3 | 2015 | 252 | 0.210 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 599 | 0.210 |
Why?
|
| Exercise Tolerance | 2 | 2020 | 54 | 0.200 |
Why?
|
| Prostheses and Implants | 2 | 2016 | 124 | 0.200 |
Why?
|
| Hypothermia, Induced | 1 | 2022 | 82 | 0.200 |
Why?
|
| Perfusion | 2 | 2022 | 236 | 0.200 |
Why?
|
| Proof of Concept Study | 1 | 2022 | 48 | 0.200 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 2 | 2015 | 53 | 0.200 |
Why?
|
| Blood Flow Velocity | 2 | 2019 | 200 | 0.190 |
Why?
|
| Propensity Score | 1 | 2022 | 148 | 0.190 |
Why?
|
| Feasibility Studies | 6 | 2020 | 786 | 0.190 |
Why?
|
| Patient Readmission | 3 | 2020 | 353 | 0.190 |
Why?
|
| Aortic Valve Stenosis | 2 | 2017 | 144 | 0.190 |
Why?
|
| Aortic Diseases | 1 | 2022 | 102 | 0.190 |
Why?
|
| Cerebrovascular Circulation | 2 | 2022 | 229 | 0.190 |
Why?
|
| Ischemic Attack, Transient | 1 | 2022 | 182 | 0.190 |
Why?
|
| Coronary Artery Disease | 2 | 2020 | 364 | 0.190 |
Why?
|
| Axillary Artery | 1 | 2020 | 10 | 0.180 |
Why?
|
| Dogs | 5 | 2010 | 704 | 0.180 |
Why?
|
| Endovascular Procedures | 2 | 2022 | 286 | 0.180 |
Why?
|
| Image Enhancement | 4 | 2017 | 567 | 0.180 |
Why?
|
| Vascular System Injuries | 1 | 2020 | 30 | 0.180 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2020 | 39 | 0.180 |
Why?
|
| Severity of Illness Index | 6 | 2019 | 1848 | 0.180 |
Why?
|
| Ambulatory Care | 2 | 2018 | 188 | 0.180 |
Why?
|
| Cause of Death | 2 | 2018 | 270 | 0.180 |
Why?
|
| Tissue Donors | 1 | 2023 | 496 | 0.170 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 91 | 0.170 |
Why?
|
| Hemoglobins | 2 | 2018 | 193 | 0.170 |
Why?
|
| Foreign Bodies | 1 | 2020 | 66 | 0.170 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 105 | 0.170 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 3473 | 0.170 |
Why?
|
| Breath Holding | 2 | 2017 | 23 | 0.170 |
Why?
|
| Drainage | 1 | 2020 | 165 | 0.170 |
Why?
|
| Postoperative Period | 1 | 2020 | 302 | 0.170 |
Why?
|
| Electric Impedance | 1 | 2020 | 110 | 0.170 |
Why?
|
| Vena Cava, Inferior | 1 | 2020 | 143 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 4 | 2018 | 864 | 0.160 |
Why?
|
| Chi-Square Distribution | 2 | 2018 | 360 | 0.160 |
Why?
|
| Delayed-Action Preparations | 2 | 2018 | 110 | 0.160 |
Why?
|
| Pneumonia, Aspiration | 1 | 2018 | 19 | 0.160 |
Why?
|
| Heparin | 1 | 2019 | 185 | 0.160 |
Why?
|
| Heart Function Tests | 1 | 2018 | 33 | 0.160 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 99 | 0.160 |
Why?
|
| Electromagnetic Phenomena | 2 | 2008 | 18 | 0.160 |
Why?
|
| Donor Selection | 1 | 2019 | 75 | 0.160 |
Why?
|
| Neuromuscular Blockade | 1 | 2018 | 26 | 0.160 |
Why?
|
| Neuromuscular Blocking Agents | 1 | 2018 | 28 | 0.160 |
Why?
|
| Operative Time | 1 | 2019 | 143 | 0.160 |
Why?
|
| Academic Medical Centers | 2 | 2018 | 385 | 0.160 |
Why?
|
| Acute Kidney Injury | 1 | 2022 | 317 | 0.160 |
Why?
|
| Predictive Value of Tests | 6 | 2021 | 1728 | 0.160 |
Why?
|
| Cicatrix | 1 | 2018 | 68 | 0.150 |
Why?
|
| Intraoperative Care | 1 | 2018 | 83 | 0.150 |
Why?
|
| Enoxaparin | 1 | 2018 | 23 | 0.150 |
Why?
|
| Prosthesis Failure | 3 | 2016 | 116 | 0.150 |
Why?
|
| Octreotide | 1 | 2018 | 26 | 0.150 |
Why?
|
| Secondary Prevention | 1 | 2018 | 158 | 0.140 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2018 | 200 | 0.140 |
Why?
|
| Algorithms | 5 | 2017 | 1892 | 0.140 |
Why?
|
| Prognosis | 5 | 2018 | 3802 | 0.140 |
Why?
|
| Patient Selection | 1 | 2020 | 684 | 0.140 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2017 | 53 | 0.140 |
Why?
|
| Aortic Aneurysm | 1 | 2017 | 80 | 0.130 |
Why?
|
| Hypertension, Pulmonary | 1 | 2020 | 353 | 0.130 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 2378 | 0.130 |
Why?
|
| Hospitalization | 1 | 2022 | 880 | 0.130 |
Why?
|
| Subtraction Technique | 1 | 2016 | 132 | 0.130 |
Why?
|
| Action Potentials | 2 | 2018 | 600 | 0.130 |
Why?
|
| Anatomic Landmarks | 1 | 2015 | 30 | 0.130 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2016 | 64 | 0.130 |
Why?
|
| Sus scrofa | 1 | 2015 | 51 | 0.130 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 1078 | 0.120 |
Why?
|
| Jehovah's Witnesses | 1 | 2015 | 20 | 0.120 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 988 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2017 | 2665 | 0.120 |
Why?
|
| Ultrasonography | 2 | 2015 | 712 | 0.120 |
Why?
|
| Myocardial Infarction | 2 | 2017 | 375 | 0.120 |
Why?
|
| Tissue and Organ Procurement | 1 | 2019 | 350 | 0.120 |
Why?
|
| Coronary Vessels | 1 | 2016 | 192 | 0.120 |
Why?
|
| Vascular Surgical Procedures | 1 | 2015 | 149 | 0.110 |
Why?
|
| Anastomosis, Surgical | 1 | 2015 | 274 | 0.110 |
Why?
|
| Heart Septum | 1 | 2014 | 47 | 0.110 |
Why?
|
| Hemolysis | 1 | 2013 | 64 | 0.110 |
Why?
|
| Illinois | 3 | 2019 | 483 | 0.110 |
Why?
|
| Software | 1 | 2017 | 666 | 0.100 |
Why?
|
| Ribs | 1 | 2012 | 46 | 0.100 |
Why?
|
| Acute Disease | 3 | 2021 | 842 | 0.100 |
Why?
|
| Survival Analysis | 2 | 2018 | 1535 | 0.100 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2017 | 244 | 0.100 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 275 | 0.100 |
Why?
|
| Therapeutics | 1 | 2011 | 12 | 0.100 |
Why?
|
| Quality of Life | 1 | 2020 | 1676 | 0.100 |
Why?
|
| Biomarkers | 1 | 2018 | 1771 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2011 | 226 | 0.090 |
Why?
|
| Cerebrovascular Disorders | 1 | 2011 | 145 | 0.090 |
Why?
|
| Saphenous Vein | 1 | 2010 | 61 | 0.090 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 306 | 0.090 |
Why?
|
| United States | 6 | 2020 | 7037 | 0.090 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2010 | 79 | 0.090 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2010 | 98 | 0.080 |
Why?
|
| Absorbable Implants | 1 | 2009 | 35 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2010 | 900 | 0.080 |
Why?
|
| Odds Ratio | 1 | 2011 | 684 | 0.080 |
Why?
|
| Vacuum | 1 | 2008 | 10 | 0.080 |
Why?
|
| Polyethylene Terephthalates | 1 | 2008 | 18 | 0.080 |
Why?
|
| Mitral Valve Prolapse | 1 | 2008 | 24 | 0.080 |
Why?
|
| Tachycardia, Supraventricular | 1 | 2008 | 16 | 0.080 |
Why?
|
| Coloring Agents | 1 | 2008 | 65 | 0.080 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 714 | 0.080 |
Why?
|
| Heart Septal Defects | 1 | 2008 | 32 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2009 | 241 | 0.080 |
Why?
|
| Capillaries | 1 | 2008 | 90 | 0.080 |
Why?
|
| Pressure | 1 | 2008 | 165 | 0.080 |
Why?
|
| Equipment Failure Analysis | 1 | 2008 | 89 | 0.070 |
Why?
|
| Immunohistochemistry | 2 | 2009 | 1802 | 0.070 |
Why?
|
| Aged, 80 and over | 4 | 2022 | 6847 | 0.070 |
Why?
|
| Benzamidines | 1 | 2007 | 2 | 0.070 |
Why?
|
| Exercise Test | 2 | 2019 | 166 | 0.070 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2007 | 136 | 0.070 |
Why?
|
| Collagen | 1 | 2008 | 294 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 1981 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 565 | 0.070 |
Why?
|
| User-Computer Interface | 1 | 2008 | 187 | 0.070 |
Why?
|
| Sex Factors | 2 | 2021 | 1070 | 0.070 |
Why?
|
| Urinary Bladder | 1 | 2008 | 250 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2008 | 887 | 0.070 |
Why?
|
| Reference Values | 2 | 2018 | 663 | 0.070 |
Why?
|
| In Vitro Techniques | 1 | 2008 | 996 | 0.070 |
Why?
|
| Age Factors | 2 | 2022 | 1876 | 0.060 |
Why?
|
| Actins | 1 | 2008 | 460 | 0.060 |
Why?
|
| Disease Progression | 2 | 2020 | 1493 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 922 | 0.060 |
Why?
|
| Observer Variation | 2 | 2016 | 612 | 0.060 |
Why?
|
| Child | 1 | 2015 | 7209 | 0.050 |
Why?
|
| Cell Movement | 1 | 2007 | 785 | 0.050 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2022 | 5 | 0.050 |
Why?
|
| Respiration | 2 | 2017 | 266 | 0.050 |
Why?
|
| Coronary Angiography | 2 | 2016 | 242 | 0.050 |
Why?
|
| Temperature | 1 | 2022 | 406 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2021 | 172 | 0.050 |
Why?
|
| Abscess | 1 | 2021 | 94 | 0.050 |
Why?
|
| Trauma Severity Indices | 1 | 2020 | 44 | 0.050 |
Why?
|
| Rats | 1 | 2007 | 4044 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2020 | 108 | 0.040 |
Why?
|
| Hemodynamic Monitoring | 1 | 2019 | 8 | 0.040 |
Why?
|
| Mammary Arteries | 1 | 2020 | 34 | 0.040 |
Why?
|
| Global Health | 1 | 2021 | 192 | 0.040 |
Why?
|
| Materials Testing | 1 | 2019 | 93 | 0.040 |
Why?
|
| Atracurium | 1 | 2018 | 5 | 0.040 |
Why?
|
| Epicardial Mapping | 1 | 2018 | 10 | 0.040 |
Why?
|
| Succinylcholine | 1 | 2018 | 14 | 0.040 |
Why?
|
| Systole | 1 | 2019 | 115 | 0.040 |
Why?
|
| Stents | 1 | 2022 | 409 | 0.040 |
Why?
|
| Organ Size | 1 | 2019 | 370 | 0.040 |
Why?
|
| Injections, Intramuscular | 1 | 2018 | 64 | 0.040 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 39 | 0.040 |
Why?
|
| Muscle Contraction | 1 | 2019 | 285 | 0.040 |
Why?
|
| Prosthesis Fitting | 1 | 2017 | 16 | 0.040 |
Why?
|
| Pneumonia | 1 | 2018 | 183 | 0.040 |
Why?
|
| Adolescent | 2 | 2020 | 9295 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2018 | 145 | 0.030 |
Why?
|
| Gadolinium | 1 | 2017 | 103 | 0.030 |
Why?
|
| Young Adult | 2 | 2018 | 6360 | 0.030 |
Why?
|
| Equipment Safety | 1 | 2016 | 33 | 0.030 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2017 | 103 | 0.030 |
Why?
|
| Gastrointestinal Agents | 1 | 2018 | 172 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 742 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2016 | 298 | 0.030 |
Why?
|
| Artifacts | 1 | 2017 | 247 | 0.030 |
Why?
|
| Cardiotonic Agents | 1 | 2015 | 89 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 2015 | 159 | 0.030 |
Why?
|
| New York | 1 | 2014 | 73 | 0.030 |
Why?
|
| Stomach | 1 | 2015 | 111 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 1944 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2016 | 451 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2020 | 3752 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2015 | 395 | 0.030 |
Why?
|
| Radiography, Abdominal | 1 | 2013 | 69 | 0.030 |
Why?
|
| Basilar Artery | 1 | 2011 | 42 | 0.020 |
Why?
|
| Vertebral Artery | 1 | 2011 | 24 | 0.020 |
Why?
|
| Acceleration | 1 | 2011 | 20 | 0.020 |
Why?
|
| Intracranial Thrombosis | 1 | 2011 | 28 | 0.020 |
Why?
|
| Contrast Media | 1 | 2017 | 1092 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2011 | 200 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2010 | 151 | 0.020 |
Why?
|
| Vascular Patency | 1 | 2010 | 129 | 0.020 |
Why?
|
| Graft Occlusion, Vascular | 1 | 2010 | 99 | 0.020 |
Why?
|
| Locomotion | 1 | 2011 | 140 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2009 | 141 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2009 | 80 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2010 | 234 | 0.020 |
Why?
|
| Prevalence | 1 | 2013 | 1246 | 0.020 |
Why?
|
| Pennsylvania | 1 | 2008 | 95 | 0.020 |
Why?
|
| Cattle | 1 | 2008 | 378 | 0.020 |
Why?
|
| Logistic Models | 1 | 2010 | 1215 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2008 | 1721 | 0.010 |
Why?
|